Invention Grant
- Patent Title: Initial relative lymphocyte count as predictive biomarker
-
Application No.: US14118213Application Date: 2012-05-16
-
Publication No.: US09772327B2Publication Date: 2017-09-26
- Inventor: Horst Lindhofer , Markus Heiss , Michael Stroehlein
- Applicant: Horst Lindhofer , Markus Heiss , Michael Stroehlein
- Applicant Address: DE Cologne DE Cologne
- Assignee: Markus Heiss,Michael Stroehlein
- Current Assignee: Markus Heiss,Michael Stroehlein
- Current Assignee Address: DE Cologne DE Cologne
- Agency: Kilpatrick Townsend & Stockton LLP
- Priority: EP11166403 20110517
- International Application: PCT/EP2012/059078 WO 20120516
- International Announcement: WO2012/156429 WO 20121122
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K38/00 ; G01N33/50 ; G01N33/574 ; C07K16/28 ; C07K16/30 ; A61K38/20 ; A61K39/00
Abstract:
The invention relates to a method for predicting an improved therapeutic benefit for an individual with a tumor load before initiating an immune therapy which is capable of activating immune cells against said tumor as well as to pharmaceutical compositions for use in this method.
Public/Granted literature
- US20150037278A1 INITIAL RELATIVE LYMPHOCYTE COUNT AS PREDICTIVE BIOMARKER Public/Granted day:2015-02-05
Information query
